With effect from 01 April 2020 Stephan Schnabel takes over as Chairman of the HELM AG Executive Board.
With this, the family-owned company will also once again be family-managed.
With the participation in the Swiss company Phargentis, HELM develops the advanced therapy of chronic obstructive pulmonary disease (COPD).
HELM opens regional Head Office in Singapore
By opening a regional Head Office in Singapore, HELM generates a dynamic growth in Asia’s emerging markets.
Share increase at Methanol Holdings (Trinidad) Ltd.
HELM increased its indirect shareholding to 25% of the shares in the production site for core products like methanol, UAN (urea ammonium nitrate solution) and melamine.
HELM acquires Spanish distribution company GEBLASA, S.A.
As a result, HELM AG strengthens its position in the Spanish market by selling inorganic chemicals
Start of local distribution activities in chemicals in Korea.
Dieter Schnabel takes over as Chairman of the Supervisory Board.
Hans-Christian Sievers becomes Chairman of the Executive Board of HELM AG on 1 January.
HELM takes a stake in Amarin Technologies.
HELM takes a stake in Amarin Technologies, S.A., Buenos Aires and therefore, in the development of special trans-dermal healing plasters with active ingredients.
In Saudi Arabia, production begins with 330,000 metric tons of vinyl acetate monomer and 460,000 metric tons of acetic acid per annum.
Of these production volumes, HELM markets 300,000 metric tons and 180,000 metric tons, respectively.
The Oman Methanol Company, in which HELM holds a stake, starts to operate the production plant in Sohar.
1.05 million metric tons of methanol are produced there each year. HELM is the exclusive marketing partner.
Richter-Helm BioLogics GmbH & Co. KG
HELM and the company Gedeon Richter from Hungary establish a subsidiary for the development and production of biotechnological pharmaceuticals.
HELM Korea Ltd. founded.
Sales revenues of the HELM Group exceed the 5 billion Euro mark for the first time, at Euro 5,811,355.
With Saudi partners HELM founds a joint venture in order to produce acetic acid and vinyl acetate monomer.
HELM invests in the Arab world.
HELM takes a stake in the Oman Methanol Company (OMC) in Sohar.
Foundation of a legally independent distribution company in Guangzhou, China, and establishment of a distribution business for chemicals
The HELM group celebrates its 100th anniversary.
HELM takes a stake in establishing a tank terminal in the port of Cochin, India.
Start to successful cooperation
Via the marketing joint venture MIDER-HELM METHANOL Vertriebs-GmbH, customers are supplied with methanol from the TOTAL refinery in Leuna, Germany.
HELM develops an individual ERP-System.
To handle the growing complexity and transactions an efficient and functional IT-system is implemented.
Science advances at HELM.
The first in-house developed pharmaceutical generic medication Calcitonin, used to combat osteoporosis, is rolled out on the market.
HELM participates in establishing a tank terminal in the port of Ningbo, People’s Republic of China.
HELM begins with marketing methanol from Trinidad & Tobago.
Today 4.1 million mt of methanol per annum are produced in five plants at that location.
Dieter Schnabel becomes Chairman of the Executive Board.
Hermann Schnabel hands the management of HELM AG over to his son with the words: "Take care Dieter." The development from trading to international marketing begins.
HELM becomes a family-owned stock corporation.
Kraeft Logistik GmbH is founded.
Own storage areas in Hamburg’s Free Port support transhipment for pharmaceuticals.
HELM moves into the building at Nordkanalstrasse 28 in Hamburg, the Group’s corporate headquarters to this day.
Now the focus also lies on Asia: HELM Japan Ltd. is founded in Tokyo. In the following decades, the international expansion was intensively pursued.
HELM dares to take the leap across the pond: HELM de México, S.A. is established in Mexico City.
The first foreign subsidiary is established: HELM Skandinavien A/S, Copenhagen.
Hermann Schnabel takes over the company from Karl O. Helm.
With primary focus on chemicals he constitutes the company that today operates worldwide.